This is the authors' abstract. We don't add key points for this paper.
Congenic strains differing by a small segment of Chromosome 9 that bears the Fv-2 locus have provided valuable material for investigating genetic resistance to Friend polycythemia virus (FV). C57BL/6 (B6) (Fv-2rr) mice have been found to differ from B6.S (Fv-2ss) mice not only in their response to this virus but also in the proliferative state of their erythropoietic progenitor cells BFU-E: in B6 mice the majority of BFU-E are normally quiescent, while in B6.S mice approximately 50% are actively synthesizing DNA at any time. We have shown that B6 but not B6.S marrow contains a macromolecule that negatively regulates DNA synthesis specifically of BFU-E in vitro. Evidence is presented that this macromolecule is a physiological negative regulator active in vivo in B6 mice. A new liquid culture system is described in which FV and erythropoietin (epo) act synergistically on Ficoll-Isopaque separated bone marrow cells to give rise after 7 days to large numbers of CFU-E detectable in 2-day plasma cultures with and without epo. Inclusion of concentrated B6 but not B6.S bone marrow supernatant in liquid cultures drastically curtailed the amplification of CFU-E by FV and epo. These studies indicate that both DNA synthesis and the BFU-E stage of differentiation are necessary conditions for initiating the effects of polycythemia-inducing FV. Genetic resistance to FV appears not to reside within the target cells for the virus.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Axelrad et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: